864 – Liraglutide for Obesity in HIV (LIROH): A Single-Arm, Open-Label Clinical Trial in South Africa
Background Obesity is a common complication of treated HIV, especially among Black Women. Yet, perceptions of optimal body weight among people living with HIV (PLWH) may influence interest in anti-obesity medical therapies. We conducted a pilot clinical trial to assess the acceptability, tolerability, and preliminary efficacy of liraglutide for obesity management in virologically suppressed PLWH…